Middle East and Africa Insulin Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Published : 30 Aug 2024

Report Type : Regional

Share This On

Download Free Sample Now Buy This Report

Home > Reports > Pharmaceuticals > Healthcare > Middle East and Africa Insulin Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Description Table of Contents Scope of the Report

Middle East and Africa Insulin Market - Size

Study Period

2018 - 2030

Base Year For Estimation

2023

Forecast Data Period

2024-2030

Historical Data Period

2018-2021

CAGR

7 %

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Insulin is a hormone; a chemical messenger produced in one part of the body to have an action on another. It is a protein responsible for regulating blood glucose levels as part of metabolism. The body manufactures insulin in the pancreas, and the hormone is secreted by its beta cells, primarily in response to glucose. The beta cells of the pancreas are perfectly designed “fuel sensors” stimulated by glucose.

The Middle East & Africa Insulin Market Segments Size & Growth:

The Middle East & Africa Insulin Market size is projected to reach approximately $ XX billion by the end of 2024 with a CAGR of close to XX% from $XX billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include Growth in the Number of Diabetic Patients, Increasing Population Exposure to Key Risk Factors Leading to Diabetes, Rising Market Demand for HI Analogs, Technological Advancements in HI Delivery Devices, and Favourable Medical Reimbursement Scenario in Developed Countries. However, Stringent Regulatory Requirements for Product Approvalisthereby hampering the market growth.

The Middle East & Africa Insulin Market Segments Share:

The Middle East & Africa Insulin Market is categorised into

Middle East and Africa Insulin Market - Growth

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

product type which comprises of drugs, and Delivery Devices. Among them, Drugs segment is expected to have largest market size during the forecast period because of its excess demand, rising proportion of the ageing population in developed countries, and Others. By Type, the market is segmented intoInsulin Analogs, Biosimilars, and Biologics. Among them, Biosimilars segment is expected to have largest market share during the forecast period because of its low-cost therapy. By Delivery Devices, the market is segmented into Syringes, Pens, and Pen Needles. Among them, Pens segment is expected to have largest market share during the forecast period because of the emerging markets. By Application, the market is segmented into Type I Diabetes, and Type II Diabetes. By Geography, Middle East holds the largest market share and is expected to maintain its dominant position during the forecast period. The changing lifestyle and lifestyle-related disorders are increasing the number of diabetic patients. High investments and involvement of more and more companies in research and development of insulin analogues and many ongoing clinical trials have created an environment for higher market growth shortly.

The Middle East & Africa Insulin

You can also purchase parts of this report. Do you want to check out a section wise price list

Middle East and Africa Insulin Market - Porter's Five Force Analysis

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Market Trends:

Technologies are being explored to make the noninvasive delivery of insulin possible. Some of the routes of insulin administration that are under investigation are oral, buccal, nasal, peritoneal and transdermal.
BD launches the first syringe designed for use with Humulin R U-500 Insulin.

The Middle East

Exclusive Benefits

Credibility and
Transparency

We actively recruit consumers, business professionals, and elusive individuals for our research panels, fostering enduring relationships. Our commitment to transparency is evident in the comprehensive listing of primary and secondary data sources, ensuring unwavering credibility in our reports.

Exhaustive
Coverage

Uncover the full spectrum with Envision Intelligence. Our detailed and extensive geographical coverage, coupled with survey consultation services, spans brand tracking, concept testing, and consumer behaviour analysis. Adapt to your evolving needs with scalable market research services that leave no facet unexplored.

Competitive
Edge

Stay ahead with Envision Intelligence. Our reports provide the latest market updates up to the date of purchase. Recognising the urgency of impactful decisions, we deliver timely analyses on the unprecedented choices made by CXOs during the COVID-19 crisis—providing valuable insights at no extra cost.

Golden
pportunities

Unearth hidden gems with Envision Intelligence. Our analysts and consultants conduct a comprehensive strategic sieve analysis, augmented by AI tools, to identify non-obvious, golden, and emerging opportunities. Evaluate possibilities that set you apart in the market.

Top-notch Reportsd
Guaranteed

Experience unparalleled depth with Envision Intelligence. Over 70% of our research is exclusive, establishing us as the premier source for in-depth and extensive market insights. Elevate your decision-making with reports that go beyond the ordinary.

Post Purchase
Support

Empower your journey with Envision Intelligence. Our commitment extends beyond the purchase. Enjoy post-purchase support for three months, with queries addressed within 24 business hours via telephone or email. We stand by you in your quest for ongoing success.